2seventy bio, Inc. (TSVT)
NASDAQ: TSVT · Real-Time Price · USD
3.140
+0.220 (7.53%)
Dec 20, 2024, 4:00 PM EST - Market closed

2seventy bio Revenue

2seventy bio had revenue of $13.53M in the quarter ending September 30, 2024, with 12.46% growth. This brings the company's revenue in the last twelve months to $45.62M, down -68.73% year-over-year. In the year 2023, 2seventy bio had annual revenue of $100.39M with 9.72% growth.

Revenue (ttm)
$45.62M
Revenue Growth
-68.73%
P/S Ratio
3.58
Revenue / Employee
$166,496
Employees
274
Market Cap
161.99M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023100.39M8.89M9.72%
Dec 31, 202291.50M36.97M67.81%
Dec 31, 202154.52M-193.60M-78.03%
Dec 31, 2020248.12M203.83M460.15%
Dec 31, 201944.30M-10.28M-18.84%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ModivCare 2.79B
Adaptimmune Therapeutics 175.04M
Sutro Biopharma 160.96M
The Joint 120.80M
Pro-Dex 56.80M
Metagenomi 55.08M
Aligos Therapeutics 6.00M
Revenue Rankings